Search for Clinical Trial Results
Chiari Malformation Type 2 - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia Condition:
|
Completed |
Study Name: Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest Condition: Actinic Keratosis Date: 2015-02-02 Interventions:
|
Terminated |
Study Name: Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus. Condition: Keratoconus Date: 2016-05-03 Interventions: Drug: Riboflavin drops Riboflavin drops were used every 2 minutes for 30 minutes on the cornea then expo |
Completed |
Study Name: Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis Condition: Keratosis Date: 2005-06-30 Interventions: Drug: imiquimod cream imiquimod 5% cream applied in doses ranging from one packet (12.5 mg) to 6 packets |
Completed |
Study Name: Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body Condition: Healthy Volunteers Date: 2010-01-28 Interventions: Drug: Rotigotine transdermal patch Rotigotine 4.5 mg/10 cm^2 patch applied for 24 hours |
Completed |
Study Name: A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) Condition: Alzheimer's Disease Date: 2008-02-14 Interventions: Drug: Rivastigmine transdermal patch The study treatment was delivered as a patch sizes 5 and 10 cm^2 co |
Completed |
Study Name: A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis Condition: Actinic Keratosis Date: 2013-08-12 Interventions:
|
Completed |
Study Name: Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects Condition: Healthy Date: 2013-01-03 Interventions: Drug: Rotigotine transdermal patch Rotigotine transdermal patch, single-dose application over 24 hours 2 |
Completed |
Study Name: Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch Condition: Healthy Date: 2008-11-14 Interventions:
|
Completed |
Study Name: Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis Condition: Actinic Keratosis Date: 2013-03-25 Interventions:
|